Increased simplicity, broader financial risk sharing, and an enhanced focus on patient care were among the recommendations developed by diverse stakeholders at a recent AMCP Partnership Forum focused on how to better manage the high costs of specialty medications.
Health Plan Executive Forum Panel #3: Specialty Pharmacy & Biosimilars - Improving Population Health
Video from the December 2014 Health Plan Executive Forum featuring Steven G. Avey, RPh, MS, FAMCP, Vice President, Specialty Programs, MedImpact Healthcare Systems, Inc.; Alan M. Lotvin, MD, Executive Vice President, CVS/specialty, CVS Health; Thomas Parry, PhD, President, Integrated Benefits Institute; and Margaret Rehayem, MA, Senior Director of Strategic Intiiatives and Communications, Midwest Business Group on Health.
